Latest Period
Q1 2026
Security Snapshot
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) Institutional Ownership
CUSIP: 09077V100
13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026
Institutions Reporting
144
Shares (Excl. Options)
34,288,673
Price
$17.49
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Symbol
- BIOA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 34,288,673
- Total 13F value
- $599,230,338
- Portfolio coverage rank
- 0%
- Share change
- +10,268,115
- Value change
- +$183,047,792
- Number of holders
- 144
- Shares outstanding
- 44,967,550
- SEC-reported price per share
- $16.62
- Insider filing price
- $16.62
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share is tracked under CUSIP 09077V100.
- 144 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 113 to 144 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $314,117,431 to $599,230,338.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 144 institutions filings for Q1 2026.
Security key
09077V100
Latest holder period
Q1 2026
13F holders
144
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
BIOA full holder history
BioAge Labs, Inc. SEC filings
BioAge Labs, Inc. company facts
BioAge Labs, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09077V100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
BIOA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 6.5% | +14% | $46,798,895 | +$13,761,500 | 2,890,605 | +42% | Cormorant Asset Management, LP | 31 Mar 2026 |
| Fortney Kristen | 7.2% | $48,279,538 | 2,704,736 | Kristen Fortney | 31 Dec 2025 | |||
| BlackRock, Inc. | 5% | $39,115,685 | 2,236,460 | BlackRock, Inc. | 31 Mar 2026 | |||
| Khosla Ventures VI, L.P. | 4% | $29,120,985 | 1,798,702 | VK Services, LLC | 15 May 2026 | |||
| RA CAPITAL MANAGEMENT, L.P. | 3.7% | $5,740,380 | 1,310,589 | RA Capital Management, L.P. | 31 Dec 2024 | |||
| ADAR1 Capital Management, LLC | 0.4% | -100% | $2,419,746 | -$32,157,900 | 135,560 | -93% | ADAR1 Capital Management, LLC | 31 Dec 2025 |
As of 31 Mar 2026, 144 institutional investors reported holding 34,288,673 shares of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA). This represents 76% of the company’s total 44,967,550 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
64%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| a16z Capital Management, L.L.C. | 7.2% | 3,233,170 | 0% | 4.4% | $56,548,143 |
| Cormorant Asset Management, LP | 6.4% | 2,890,605 | +42% | 2.5% | $50,556,681 |
| Sofinnova Investments, Inc. | 5.1% | 2,293,788 | 0% | 2% | $40,118,352 |
| BlackRock, Inc. | 5% | 2,267,756 | +48% | 0% | $39,663,052 |
| JANUS HENDERSON GROUP PLC | 4.7% | 2,094,270 | +412% | 0.02% | $36,597,368 |
| Octagon Capital Advisors LP | 3.9% | 1,748,000 | +9.4% | 3.4% | $30,572,520 |
| RA CAPITAL MANAGEMENT, L.P. | 3.7% | 1,650,648 | 0.31% | $28,869,834 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3% | 1,354,906 | 0% | 0% | $23,697,306 |
| Balyasny Asset Management L.P. | 3% | 1,327,545 | 0.05% | $23,218,762 | |
| BRAIDWELL LP | 2.7% | 1,200,587 | 0.7% | $20,998,267 | |
| Polar Capital Holdings Plc | 2.5% | 1,132,640 | 0.09% | $19,809,874 | |
| STATE STREET CORP | 1.9% | 850,894 | +101% | 0% | $14,882,136 |
| Sands Capital Alternatives, LLC | 1.7% | 786,353 | 0% | 3.3% | $13,753,314 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 749,266 | +27% | 0% | $13,108,547 |
| ORBIMED ADVISORS LLC | 1.6% | 711,811 | -10% | 0.28% | $12,449,574 |
| D. E. Shaw & Co., Inc. | 1.6% | 699,190 | +106% | 0.01% | $12,228,833 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.5% | 653,374 | 0% | 4.1% | $11,427,511 |
| COSMIC MANAGEMENT, LLC | 1.1% | 501,833 | 0% | 3.8% | $8,777,059 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.1% | 500,000 | -52% | 0.01% | $8,745,000 |
| MILLENNIUM MANAGEMENT LLC | 0.96% | 430,463 | +88% | 0.01% | $7,528,798 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.93% | 420,123 | +26% | 0.03% | $7,347,951 |
| ACADIAN ASSET MANAGEMENT LLC | 0.87% | 392,346 | +41% | 0.01% | $6,856,000 |
| STEMPOINT CAPITAL LP | 0.75% | 338,654 | 1.1% | $5,923,058 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.64% | 286,946 | 0% | 0% | $5,018,686 |
| Comprehensive Financial Management LLC | 0.6% | 271,842 | 0% | 0.16% | $4,754,517 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Latest
Q1 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 34,288,673 | $599,230,338 | +$183,047,792 | $17.49 | 144 |
| 2025 Q4 | 23,662,525 | $314,117,431 | +$36,761,604 | $13.23 | 113 |
| 2025 Q3 | 21,259,082 | $125,003,330 | +$3,516,038 | $5.88 | 92 |
| 2025 Q2 | 20,716,453 | $85,559,282 | +$3,327,577 | $4.13 | 81 |
| 2025 Q1 | 20,278,591 | $76,157,053 | +$1,658,645 | $3.76 | 65 |
| 2024 Q4 | 19,641,111 | $113,720,000 | -$68,696,192 | $5.79 | 64 |
| 2024 Q3 | 20,709,688 | $430,774,211 | +$424,388,861 | $20.80 | 58 |